46. The pulse on the industry - BioPlan and the Biopharma Resilience Index

<p>For this episode of <em>Discovery Matters</em> we are focusing on industry surveys, including BioPlan and the Biopharma Resilience Index. Both huge reports provide insights into issues within the industry.</p> <p>Firman Ghouze, Cytiva’s Managing Director in APAC, discusses how the Biopharma Resilience Index came about, its insights, and what issues need addressing. We are also joined by Eric Langer, from BioPlan Associates, who shared the BioPlan findings, many of which coincided with the results we found. Lastly, we were delighted to be joined by Dr. Richard Wang, the founder and CEO of Neukio Biotherapeutics, who shared his insight as an industry leader.</p> <p>This episode is an informative and accessible discussion on the biopharma industries’ needs and possible solutions being taken to amend these issues.</p> <p>Learn more about the Biopharma Resilience Index <a href="https://www.cytivalifesciences.com/about-us/global-biopharma-resilience-index" target="_blank">here</a>.</p> <p>Learn more about the BioPlan <a href="https://www.bioplanassociates.com/wp-content/uploads/2021/07/18th-Annual-Biomfg-Report-Brochure-21-0513-1.pdf" target="_blank">here</a>.</p>